These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 18626480)

  • 21. Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection.
    Vokaer B; Van Rompaey N; Lemaître PH; Lhommé F; Kubjak C; Benghiat FS; Iwakura Y; Petein M; Field KA; Goldman M; Le Moine A; Charbonnier LM
    J Immunol; 2010 Sep; 185(6):3417-25. PubMed ID: 20733201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection.
    Le Moine A; Flamand V; Demoor FX; Noël JC; Surquin M; Kiss R; Nahori MA; Pretolani M; Goldman M; Abramowicz D
    J Clin Invest; 1999 Jun; 103(12):1659-67. PubMed ID: 10377172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ia antigens and epidermal Langerhans cells.
    Streilein JW; Bergstresser PR
    Transplantation; 1980 Nov; 30(5):319-23. PubMed ID: 7006163
    [No Abstract]   [Full Text] [Related]  

  • 24. Early IL-10 production is essential for syngeneic graft acceptance.
    Takiishi T; Tadokoro CE; Rizzo LV; de Moraes LV
    J Leukoc Biol; 2012 Aug; 92(2):259-64. PubMed ID: 22416256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro production and transplantation of immunologically active skin equivalents.
    Rouabhia M
    Lab Invest; 1996 Oct; 75(4):503-17. PubMed ID: 8874382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
    Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rejection of transgenic skin expressing a xeno-class I antigen is CD4-dependent and CD8-independent.
    Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
    Transplant Proc; 1990 Jun; 22(3):1059-60. PubMed ID: 1971971
    [No Abstract]   [Full Text] [Related]  

  • 29. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice.
    Gordon EJ; Kelkar V
    Xenotransplantation; 2009; 16(3):135-44. PubMed ID: 19566653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
    DeBenedette MA; Wen T; Bachmann MF; Ohashi PS; Barber BH; Stocking KL; Peschon JJ; Watts TH
    J Immunol; 1999 Nov; 163(9):4833-41. PubMed ID: 10528184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of photochemical treatment on immunogenicity and epidermal Langerhans cells of murine skin grafts.
    Gruner S; Meffert H
    Biomed Biochim Acta; 1986; 45(5):649-54. PubMed ID: 2944515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of rejection of MHC class I-disparate murine skin grafts--histological and immunohistochemical studies of the rejection phenomenon.
    Kobayashi E; Kawai K; Ito M; Matsumoto Y; Fujiwara M
    Transplant Proc; 1990 Oct; 22(5):2352-7. PubMed ID: 2219400
    [No Abstract]   [Full Text] [Related]  

  • 34. Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice.
    Coates PT; Krishnan R; Kireta S; Johnston J; Russ GR
    Gene Ther; 2001 Aug; 8(16):1224-33. PubMed ID: 11509955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice.
    Wecker H; Grusby MJ; Auchincloss H
    Transplantation; 1995 Apr; 59(8):1223-7. PubMed ID: 7732570
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity.
    Kaplan DH; Jenison MC; Saeland S; Shlomchik WD; Shlomchik MJ
    Immunity; 2005 Dec; 23(6):611-20. PubMed ID: 16356859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase activity is required for skin Langerhans cell maturation and phagocytosis.
    Qi R; Liu M; Gao XH; Yu FS; Chen HD; Lim HW; Zhou L; Mi QS
    J Dermatol Sci; 2012 Feb; 65(2):152-5. PubMed ID: 22222421
    [No Abstract]   [Full Text] [Related]  

  • 38. Delayed allograft rejection by T cell receptor V beta 8.1 transgenic mice peripherally tolerized to Mls-1.
    Bhandoola A; Bassiri H; Markmann JF; Yui K; Hashimoto Y; Greene MI
    Eur J Immunol; 1994 Jul; 24(7):1710-3. PubMed ID: 7913041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties.
    Bergstresser PR; Fletcher CR; Streilein JW
    J Invest Dermatol; 1980 Feb; 74(2):77-80. PubMed ID: 6985948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Langerhans cell depleted allograft skin on excised burns.
    Alsbjörn BF
    Lancet; 1983 May; 1(8333):1106. PubMed ID: 6133135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.